Therapeutic effects of all trans-retinoitc acid combined with transarterial chemoembolization on Walker-256 hepatoma in rats

Abstract

In order to investigate the inhibitory effects of all trans-retinoitc acid (ATRA) on differentiation and apoptosis of Walker-256 hepatocellular carcinoma cells and the therapeutic effects of ATRA combined with transarterial chemoembolization (TACE) on rat Walker-256 transplanted hepatocarcinoma, Walker-256 hepatocarcinoma cell lines were treated with ATRA at different concentrations. After culture for 48 h, the inhibitory rate of cell proliferation was determined by MTT assay; the changes of Fas and Bcl-2 mRNA expression were determined by RT-PCR, and the expression levels of Caspase3 and Caspase8 proteins were detected by Western blot. Twenty-seven Wistar rat models of hepatocarcinoma were set up successfully by implanting Walker-256 cell lines. The tumor volume at the 11th day after implantation (V_preoperation) was measured by magnetic resonance imaging (MRI). The 27 rats were randomly and equally divided into three groups, and the therapy scheme was performed as follows: group A (ATRA 0.1 mg+mitomycin 0.05 mL+lipiodol 0.05 mL+gelfoam powder 0.025 mg); group B (mitomycin 0.05 mg+lipiodol 0.05 ml+gelfoam 0.025 mg; group C (0.9% NaCl 0.2 mL). After another 11 days, MRI was performed once again to measure the tumor volume (V_{postoperation}). The expression of factor and Ki VIII -67 in the tumor tissues was detected by immunohistochemistry. The results showed that ATRA could suppress proliferation of Walker-256 cell lines. After treatment of Walker-256 cell lines with ATRA, the expression of Fas mRNA was significantly up-regulated and the Bcl-2 mRNA was significantly down-regulated by ATRA at the concentration of 10 μmol/L as compared with the control group (P<0.05). After treatment with 10 μmol/L ATRA for 48 h, the Caspase3 and Caspase8 were significantly activated as compared with the control group (P<0.05). Significant difference existed in growth rate among the three groups (P<0.01) and between either two groups (P<0.05). The expression rate of factor VIII and Ki-67 was gradually increased from group A, group B to group C. The study suggests that ATRA could inhibit the proliferation of Walker-256 cells and the effectiveness of the combined therapy (ATRA+TACE) for treating transplanted hepatoma of rats is superior to that of TACE alone.

Keywords

all trans-retinoitc acid / hepatocarcinoma transarterial chemoembolization / induced differentiation / apoptosis / transplanted hepatoma / Walker-256 hepatocarcinoma cell / rats

References

[1] Van DekkenH., VerhoefC., WinkJ., et al.. Cell biological evaluation of liver cell carcinoma, dysplasia and adenoma by tissue micro-array analysis. Acta Histochem, 2005, 107(3): 161-171

[2] SergioA., CristoforiC., CardinR., et al.. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness. Am J Gastroenterol, 2008, 103(4): 914-921

[3] Wang CT, Meng M, Zhang JC, et al. Growth inhibition and gene induction in human hepatocellular carcinoma cell exposed to sodium 4-phenylbutanoate. Chin Med J (Engl), 121(17):1707–1711

[4] YinC., LinY., ZhangX., et al.. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene. Hepatology, 2008, 48(5): 1528-1539

[5] BertagnoloV., GrassilliS., BavelloniA., et al.. Vav1 modulates protein expression during ATRA-induced maturation of APL-derived promyelocytes: a proteomic-based analysis. J Proteome Res, 2008, 7(9): 3729-3736

[6] CordobaR., RamirezE., LeiS.H., et al.. Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acid. Eur J Clin Pharmacol, 2008, 64(10): 1031-1032

[7] MaitiT.K., GhoshK.S., DebnathJ., et al.. Binding of all-trans retinoic acid to human serum albumin: fluorescence, FT-IR and circular dichroism studies. Int J Biol Macromol, 2006, 38(3–5): 197-202

[8] ArceF., Gätjens-BonicheO., VargasE., et al.. Apoptotic events induced by naturally occurring retinods ATRA and 13-cis retinoic acid on human hepatoma cell lines Hep3B and HepG2. Cancer Lett, 2005, 229(2): 271-281

[9] ZhengG.H., LiH.Q.. Effects of garlic oil combined with resveratrol on inducting of apoptosis and expression of Fas, bcl-2 and bax in human gastric cancer cell line. Zhonghua Yu Fang Yi Xue Za Zhi (Chinese), 2008, 42(1): 39-42

[10] DasA., BanikN.L., RayS.K.. Retinoids induce differentiation and downregulate telomerase activity and N-Myc to increase sensitivity to flavonoids for apoptosis in human malignant neuroblastoma SH-SY5Y cells. Int J Oncol, 2009, 34(3): 757-765

[11] LueH., ThieleM., FranzJ., et al.. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene, 2007, 26(35): 5046-5059

[12] BrombergK.D., KlugerH.M., DelaunayA., et al.. Increased expression of the E3 ubiquitin ligase RNF5 is associated with decreased survival in breast cancer. Cancer Res, 2007, 67(17): 8172-8179

[13] SpaldingK.L., DharmarajanA.M., HarveyA.R.. Caspaseindependent retinal ganglion cell death after target ablation in the neonatal rat. Eur J Neurosci, 2005, 21(1): 33-45

[14] GilbertS., RuelA., LorangerA., et al.. Switch in Fas-activated death signaling pathway as result of keratin 8/18-intermediate filament loss. Apoptosis, 2008, 13(12): 1479-1493

[15] NorrisK.L., YouleR.J.. Cytomegalovirus proteins vMIA and m38.5 link mitochondrial morphogenesis to Bcl-2 family proteins. J Virol, 2008, 82(13): 6232-6243

[16] TophkhaneC., YangS., BalesW., et al.. Bcl-2 overexpression sensitizes MCF-7 cells to genistein by multiple mechanisms. Int J Oncol, 2007, 31(4): 867-874

[17] SzajerkaA., DziegielP., SzajerkaT., et al.. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cor tex. Anticancer Res, 2008, 28(5B): 2959-2965

[18] JamaliM., ChettyR.. Predicting prognosis in gastroentero- pancreatic neuroendocrine tumors: an overview and the value of Ki-67 immunostaining. Endocr Pathol, 2008, 19(4): 282-288

[19] García-VelascoA., MendiolaC., Sánchez-MuñozA., et al.. Prognostic value of hormonal receptors, p53, ki67 and HER2/neu expression in epithelial ovarian carcinoma. Clin Transl Oncol, 2008, 10(6): 367-371

[20] KoideN., NishioA., SatoT., et al.. Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus. Am J Gastroenterol, 2004, 99(9): 1667-1674

[21] LiuY.M., YangG.W., BaiS.M., et al.. Expression of C-erb B-2 and its relation to angiogenesis in nasopharyngeal carcinoma. Nan Fang Yi Ke Da Xue Xue Bao (Chinese), 2007, 27(10): 1588-1589

[22] RobertC., DelvaL., BalitrandN., et al.. Apoptosis induction by retinoids in eosinophilic leukemia cells: implication of retinoic acid receptor-alpha signaling in all-trans-retinoic acid hypersensitivity. Cancer Res, 2006, 66(12): 6336-6344

[23] TarkanyiI., DudognonC., HillionJ., et al.. Retinoid/arsenic combination therapy of promyelocytic leukemia: induction of telomerase-dependent cell death. Leukemia, 2005, 19(10): 1806-1811

[24] LiuY.B., XuB., WangJ.W., et al.. Effects of all-trans retinoic acid on expression of connexin genes and gap junction communication in hepatocellular carcinoma cell lines. Zhonghua Yi Xue Za Zhi (Chinese), 2005, 85(20): 1414-1418

[25] SuzukiS., KawakamiS., ChansriN., et al.. Inhibition of pulmonary metastasis in mice by all-trans retinoic acid incorporated in cationic liposomes. J Control Release, 2006, 116(1): 58-63

[26] KojimaS., OkunoM., Matsushima-NishiwakiR., et al.. Acyclic retinoid in the chemoprevention of hepatocellular carcinoma. Int J Oncol, 2004, 24(4): 797-805